Medicine and Dentistry
Ion Channel
100%
Amiloride
100%
Epithelial Sodium Channel
100%
Gastrointestinal Tract
50%
Combination Therapy
50%
Gut
50%
Osteoplasty
50%
Sodium Ion
50%
Potassium Channel
50%
Side Effect
50%
Cancer Inhibition
50%
Medical Decision Making
50%
Organoid
50%
Bone Cancer
50%
Osteosarcoma
50%
Channel Blocker
50%
Castration Resistant Prostate Cancer
50%
Bone Remodeling
50%
Bioluminescence
50%
Diseases
50%
Keyphrases
MiR-223
100%
Epithelial Sodium Channel (ENaC)
100%
Sodium Channel Blockade
100%
Amiloride
66%
Prostate
33%
Gastrointestinal Tract
33%
Epithelium
33%
Cancer Patients
33%
Site of Disease
33%
K Channels
33%
Bone Tumor
33%
Bone Remodeling
33%
Therapeutic Efficacy
33%
Tolerability
33%
Tumor Inhibition
33%
Ion Channels
33%
Bioluminescence Imaging
33%
Osteosarcoma
33%
Channel Blocker
33%
Organoids
33%
Castration-resistant Prostate Cancer
33%
Enteroids
33%
Alpha Particles
33%
Clinical Approach
33%
Channel Activator
33%
Reduced Side Effects
33%
Pharmacology, Toxicology and Pharmaceutical Science
Ion Channel
100%
Amiloride
100%
Epithelial Sodium Channel
100%
Combination Therapy
50%
Malignant Neoplasm
50%
Sodium Ion
50%
Side Effect
50%
Potassium Channel
50%
Bone Tumor
50%
Bone Cancer
50%
Tolerability
50%
Cancer Inhibition
50%
Channel Blocker
50%
Osteosarcoma
50%
Castration Resistant Prostate Cancer
50%
Diseases
50%